Literature DB >> 17109350

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Jovanka M Voyich1, Michael Otto, Barun Mathema, Kevin R Braughton, Adeline R Whitney, Diane Welty, R Daniel Long, David W Dorward, Donald J Gardner, Gérard Lina, Barry N Kreiswirth, Frank R DeLeo.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) remains a major problem in hospitals, and it is now spreading in the community. A single toxin, Panton-Valentine leukocidin (PVL), has been linked by epidemiological studies to community-associated MRSA (CA-MRSA) disease. However, the role that PVL plays in the pathogenesis of CA-MRSA has not been tested directly. To that end, we used mouse infection models to compare the virulence of PVL-positive with that of PVL-negative CA-MRSA representing the leading disease-causing strains. Unexpectedly, strains lacking PVL were as virulent in mouse sepsis and abscess models as those containing the leukotoxin. Isogenic PVL-negative (lukS/F-PV knockout) strains of USA300 and USA400 were as lethal as wild-type strains in a sepsis model, and they caused comparable skin disease. Moreover, lysis of human neutrophils and pathogen survival after phagocytosis were similar between wild-type and mutant strains. Although the toxin may be a highly linked epidemiological marker for CA-MRSA strains, we conclude that PVL is not the major virulence determinant of CA-MRSA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109350     DOI: 10.1086/509506

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  249 in total

1.  Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.

Authors:  Pauline Yoong; Gerald B Pier
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

3.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

4.  Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins.

Authors:  Benoît-Joseph Laventie; Hendrik Jan Rademaker; Maher Saleh; Ernie de Boer; Rick Janssens; Tristan Bourcier; Audrey Subilia; Luc Marcellin; Rien van Haperen; Joyce H G Lebbink; Tao Chen; Gilles Prévost; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

5.  Do differences in Panton-Valentine leukocidin production among international methicillin-resistant Staphylococcus aureus clones affect disease presentation and severity?

Authors:  Eve Boakes; Angela M Kearns; Cederic Badiou; Gerard Lina; Robert L Hill; Matthew J Ellington
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 6.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

7.  Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin?

Authors:  Christopher P Montgomery; Robert S Daum
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Bioinformatics and Molecular Biological Characterization of a Hypothetical Protein SAV1226 as a Potential Drug Target for Methicillin/Vancomycin-Staphylococcus aureus Infections.

Authors:  Nichole Haag; Kimberly Velk; Tyler McCune; Chun Wu
Journal:  World Acad Sci Eng Technol       Date:  2015-06

9.  Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor.

Authors:  Michael E Olson; Tyler K Nygaard; Laynez Ackermann; Robert L Watkins; Oliwia W Zurek; Kyler B Pallister; Shannon Griffith; Megan R Kiedrowski; Caralyn E Flack; Jeffrey S Kavanaugh; Barry N Kreiswirth; Alexander R Horswill; Jovanka M Voyich
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

10.  Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections.

Authors:  Ronald N Jones; Angela M Nilius; Bolanle K Akinlade; Lalitagauri M Deshpande; Gerard F Notario
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.